The impact of HLA on long-term outcome after thymectomy for myasthenia gravis
- 1 August 1998
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 88 (1-2) , 177-181
- https://doi.org/10.1016/s0165-5728(98)00120-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Long-Term Outcome and Quality of Life After Thymectomy for Myasthenia GravisAnnals of Surgery, 1996
- Nomenclature for factors of the HLA system, update March 1995Tissue Antigens, 1995
- Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis ratsEuropean Journal of Immunology, 1995
- A one-step monoclonal antibody typing procedure that simplifies HLA class I and class II typingTissue Antigens, 1994
- Identification of genomic typing of non-DR3 HLA class II genes associated with myasthenia gravisJournal of Neuroimmunology, 1993
- Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associationsTissue Antigens, 1991
- HLA‐DR, DO AND DP TYPING USING PCR AMPLIFICATION AND IMMOBILIZED PROBESInternational Journal of Immunogenetics, 1991
- The Role of the Thymus in Myasthenia Gravis: Immunohistological and Immunological Studies in 115 CasesaAnnals of the New York Academy of Sciences, 1987
- Muscle acetylcholine receptor loss in murine experimental autoimmune myasthenia gravis: Correlated with cellular, humoral and clinical responsesJournal of Neuroimmunology, 1985
- THYMIC MYOGENESIS, T-LYMPHOCYTES AND THE PATHOGENESIS OF MYASTHENIA GRAVISAnnals of the New York Academy of Sciences, 1981